Telehealth & Digital Health

As the home healthcare market booms, BrightStar Care's top franchise ranking reveals a powerful model blending clinical rigor with a scalable franchise system.

LRM Aesthetics' new delivery system for its PDGF+ formula isn't just a product update; it’s a masterclass in how small innovations create major workflow gains.

A biotech firm's non-hallucinogenic drug just passed a key safety test. Could this novel approach finally disrupt the challenging world of alcohol use disorder?

An event in Toronto features families devastated by CTE, sparking a national conversation on the safety of contact sports for children and institutional response.

Apollo Athenaa's new handbook addresses caregiver burnout, offering a vital resource to the unsung heroes of India's growing cancer crisis.

Crescom's AI is being tested at Mass General Brigham, aiming to ease radiologist burnout and establish a critical foothold in the competitive US MedTech market.

The 8th annual 'Shine the Light' campaign unites 47 groups to fight Sickle Cell Disease, but behind the red-lit landmarks lies a deeper crisis of access to new, multi-million dollar cures.

Pharma giant MSD and health-tech innovator Nivi are using an AI chatbot to fight cervical cancer in Asia. Can this model overcome regulatory hurdles and scale?

Acurx Pharma's new drug, ibezapolstat, offers a novel weapon against deadly infections like C. diff by sparing good bacteria. Is this the breakthrough we need?

Strive Health's new CMO and CFO hires signal a strategic acceleration in value-based kidney care, blending clinical innovation with financial AI deployment.

The company behind the first FDA-cleared birth control app is expanding into a holistic wellness platform, a strategic move that could redefine the FemTech market.

A new survey reveals an overwhelming public demand to treat epinephrine like defibrillators. This isn't just about allergies; it's a systemic shift in our definition of public safety.

A new AI platform promises to slash drug development red tape. But can it overcome the industry’s deep-rooted challenges of privacy, trust, and integration?

Renowned cancer researcher Dr. Morag Park takes the helm at the Gairdner Foundation, a key predictor of Nobel Prizes. What does this strategic move mean for global science?

A simple blood test for lung cancer completes key validation, signaling potential disruption for the diagnostics market and major savings for healthcare systems.

How a small industrial city in China pivoted from chemical production to dominate the $3.8B global smart cat litter market with a high-tech health solution.

Preliminary data from a randomized trial suggests a personalized medicine approach can reverse cognitive decline, offering a glimmer of hope beyond slowing the disease.

Speediance's new partnership with ATHX signals a major shift, moving advanced digital training from the living room to the world of competitive fitness.

Dignitas's recent championship, powered by cognitive supplements, signals a major shift away from energy drinks and toward a new era of player wellness.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?